Go Pro
→ Greatest Hedge Fund Manager of All Time: Get Out of Stocks (From TradeSmith) (Ad)tc pixel Free SBFMW Stock Alerts

Sunshine Biopharma (SBFMW) Competitors

Sunshine Biopharma logo
$0.05 -0.01 (-16.67%)
Closing price 07/1/2026 03:59 PM Eastern
Extended Trading
$0.05 0.00 (-1.00%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

SBFMW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Sunshine Biopharma stock or one of its competitors? MarketBeat compares Sunshine Biopharma with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sunshine Biopharma include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Sunshine Biopharma compare to Ainos?

Sunshine Biopharma (NASDAQ:SBFMW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sunshine Biopharma$35.49MN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

In the previous week, Ainos had 1 more articles in the media than Sunshine Biopharma. MarketBeat recorded 2 mentions for Ainos and 1 mentions for Sunshine Biopharma. Sunshine Biopharma's average media sentiment score of 1.92 beat Ainos' score of 1.43 indicating that Sunshine Biopharma is being referred to more favorably in the media.

Company Overall Sentiment
Sunshine Biopharma Very Positive
Ainos Positive

Company Net Margins Return on Equity Return on Assets
Sunshine BiopharmaN/A N/A N/A
Ainos N/A N/A N/A

Summary

Sunshine Biopharma beats Ainos on 2 of the 3 factors compared between the two stocks.

How does Sunshine Biopharma compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Sunshine Biopharma (NASDAQ:SBFMW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.

In the previous week, Alvotech had 1 more articles in the media than Sunshine Biopharma. MarketBeat recorded 2 mentions for Alvotech and 1 mentions for Sunshine Biopharma. Sunshine Biopharma's average media sentiment score of 1.92 beat Alvotech's score of 0.69 indicating that Sunshine Biopharma is being referred to more favorably in the news media.

Company Overall Sentiment
Alvotech Positive
Sunshine Biopharma Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$559.42MN/AN/AN/AN/A
Sunshine Biopharma$35.49MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Sunshine Biopharma N/A N/A N/A

Summary

Alvotech beats Sunshine Biopharma on 2 of the 3 factors compared between the two stocks.

How does Sunshine Biopharma compare to Aravive?

Aravive (NASDAQ:ARAV) and Sunshine Biopharma (NASDAQ:SBFMW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, risk and dividends.

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Sunshine Biopharma N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Sunshine Biopharma$35.49MN/AN/AN/AN/A

In the previous week, Sunshine Biopharma had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Sunshine Biopharma and 0 mentions for Aravive. Sunshine Biopharma's average media sentiment score of 1.92 beat Aravive's score of 0.00 indicating that Sunshine Biopharma is being referred to more favorably in the news media.

Company Overall Sentiment
Aravive Neutral
Sunshine Biopharma Very Positive

Summary

Sunshine Biopharma beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Sunshine Biopharma compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Sunshine Biopharma (NASDAQ:SBFMW) are both pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, media sentiment, earnings and profitability.

In the previous week, Sunshine Biopharma had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Sunshine Biopharma and 0 mentions for Atlantic Coastal Acquisition Corp. II. Sunshine Biopharma's average media sentiment score of 1.92 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Sunshine Biopharma is being referred to more favorably in the news media.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Sunshine Biopharma Very Positive

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
Sunshine Biopharma N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
Sunshine Biopharma$35.49MN/AN/AN/AN/A

Summary

Sunshine Biopharma beats Atlantic Coastal Acquisition Corp. II on 3 of the 3 factors compared between the two stocks.

How does Sunshine Biopharma compare to Biofrontera?

Sunshine Biopharma (NASDAQ:SBFMW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends.

Company Net Margins Return on Equity Return on Assets
Sunshine BiopharmaN/A N/A N/A
Biofrontera N/A N/A N/A

In the previous week, Biofrontera had 1 more articles in the media than Sunshine Biopharma. MarketBeat recorded 2 mentions for Biofrontera and 1 mentions for Sunshine Biopharma. Sunshine Biopharma's average media sentiment score of 1.92 beat Biofrontera's score of 1.44 indicating that Sunshine Biopharma is being referred to more favorably in the media.

Company Overall Sentiment
Sunshine Biopharma Very Positive
Biofrontera Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sunshine Biopharma$35.49MN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

Summary

Biofrontera beats Sunshine Biopharma on 2 of the 3 factors compared between the two stocks.

Get Sunshine Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBFMW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBFMW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBFMW vs. The Competition

Export
MetricSunshine BiopharmaDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.51B$6.79B$12.60B
Dividend YieldN/A2.84%2.66%6.14%
P/E RatioN/A5.1627.4325.27
Price / SalesN/A1,652.75537.9499.25
Price / CashN/A10.1847.9959.26
Price / BookN/A10.8711.026.62
Net IncomeN/A$20.27B$3.57B$336.83M
7 Day PerformanceN/A1.23%2.90%3.25%
1 Month PerformanceN/A-0.29%3.71%0.92%
1 Year PerformanceN/A9.36%34.39%27.62%

Sunshine Biopharma Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBFMW
Sunshine Biopharma
N/A$0.05
-16.7%		N/A-77.3%$0.00$35.49MN/A3
AIMDW
Ainos
N/A$0.10
-26.5%		N/A-5.4%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.25
flat		N/A-89.8%$0.00$559.42MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SBFMW) was last updated on 7/2/2026 by MarketBeat.com Staff.
From Our Partners
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Urgent exposé on the "Mar-a-Lago Trade"
Dr. David Eifrig, former Goldman Sachs VP and Senior Partner at Stansberry Research, has released an urgent ex...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Gold Is About to Do Something It Hasn’t in 90 Years
The U.S. Treasury still carries America's gold reserves at $42 per ounce — a price set generations ago. Buried...
US Gold Bureau | Sponsoredtc pixel
What Happens to Your Assets If You Die Without a Will?
Without a will, your state's intestacy laws decide how your assets are divided — a rigid formula that ignores ...
SmartAsset | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel